TransNL/Post Math Framework License Agreement
Version 2.0
Effective Date: June 2025
Framework Creator: Jesús Manuel Soledad Terrazas
PREAMBLE
The TransNL (Transcendent Natural Language)/Post Math Framework represents a fundamental advancement in human reasoning capabilities, providing reality-native cognitive operations that transcend traditional mathematical limitations. This license ensures that humanity’s greatest challenges can be addressed freely while maintaining fair compensation for commercial value creation derived from the Framework.
Core Principle: Empowering humanity with reality-native cognition while ensuring responsible development and sustainable innovation.
SECTION 1: DEFINITIONS
1.1 Framework Components
“TransNL/Post Math Framework” includes:
• All TransNL/Post Math operations, syntax, and semantic structures
• The Soledad Method and its applications
• All related papers, documentation, and implementation guides
• Software implementations, code examples, and training materials
• Any derivative works or extensions of the core framework
1.2 Use Categories
“Humanitarian Use” means:
• Medical research, disease treatment, drug discovery, and therapeutic development
• Clinical applications and patient care optimization
• Public health research and epidemiological studies
• Climate science and environmental protection research
• Educational applications in accredited institutions
• Pure scientific research without commercial intent
• Non-profit humanitarian applications
“Commercial Use” means:
• For-profit business applications or product development
• Revenue-generating services or consulting
• Financial trading, investment, or market analysis systems
• Enterprise software or platform development
• Any application generating direct or indirect commercial advantage
“Research-to-Commercial Bridge” means:
• Commercialization of discoveries made using TransNL/Post Math under Humanitarian Use
• Products, services, or IP derived from TransNL/Post Math-enabled research
• Commercial applications of insights gained through TransNL/Post Math research
• Any monetization of research outputs that utilized TransNL/Post Math
1.3 Key Entities
“Creator” means Jesús Manuel Soledad Terrazas
“Licensee” means any individual or entity using the TransNL/Post Math Framework
“Commercial Value” means revenues, valuations, licensing fees, or other economic benefits
SECTION 2: GRANT OF RIGHTS
2.1 Humanitarian Use License
FREE, WORLDWIDE, NON-EXCLUSIVE LICENSE granted for:
• Medical research and treatment development
• Scientific research addressing global challenges
• Educational use in academic institutions
• Non-profit humanitarian applications
No fees, no restrictions, immediate access.
2.2 Attribution Requirements (All Uses)
Mandatory for all applications:
• “This work utilizes the TransNL/Post Math Framework developed by Jesús Manuel Soledad Terrazas”
• Citation of primary TransNL/Post Math papers in all publications
• Clear acknowledgment in presentations, reports, and documentation
• Notification to Creator of significant applications or discoveries
2.3 Commercial Use Requirements
All Commercial Use requires:
• Express written commercial license agreement
• Licensing fees and/or revenue sharing arrangements
• Compliance with commercial license terms
• Ongoing reporting and audit compliance
SECTION 3: RESEARCH-TO-COMMERCIAL BRIDGE FRAMEWORK
3.1 Commercialization Trigger Events
Automatic commercialization obligations apply when:
• Research conducted under Humanitarian Use leads to commercial products
• IP created using TransNL/Post Math is licensed, sold, or commercialized
• Companies are formed to exploit TransNL/Post Math-enabled discoveries
• Investment funding is secured for TransNL/Post Math-derived technologies
• Revenue exceeds $100,000 annually from TransNL/Post Math-enabled work
3.2 Creator Participation Rights
When Trigger Events occur, Creator receives:
Tier 1 – Research Discoveries:
• 3-8 % of net revenues from products/services directly derived from TransNL/Post Math research
• 1-3 % of company valuations when TransNL/Post Math research is core to the business model
• Minimum \$50,000 annual licensing fee for enterprise applications
Tier 2 – Breakthrough Applications:
• 5-12 % of net revenues for transformative medical or scientific breakthroughs
• 2-5 % of company valuations for unicorn companies built on TransNL/Post Math insights
• Preferred terms for follow-on commercial licensing
Tier 3 – Platform Applications:
• 8-15 % of net revenues when TransNL/Post Math becomes core infrastructure
• 3-7 % of company valuations for platform companies
• Board advisory position option for major applications
3.3 Calculation and Payment Terms
Revenue Sharing Methodology:
• Net revenues = gross revenues minus cost of goods sold and direct expenses
• Quarterly reporting and payment requirements
• Independent audit rights with certified accounting
• Minimum annual payments regardless of profitability
Valuation-Based Payments:
• Triggered by funding rounds, acquisitions, or IPO events
• Based on enterprise value minus tangible assets
• Payable in cash, equity, or combination (Creator’s choice)
• Anti-dilution protections for equity components
SECTION 4: COMMERCIAL LICENSING STRUCTURE
4.1 Licensing Tiers
Startup License (\$25,000-\$100,000 annually):
• Companies <\$10 M valuation or <\$2 M annual revenue
• 2-5 % revenue sharing on TransNL/Post Math-enabled products
• Simplified reporting requirements
• Growth escalation clauses
Enterprise License (\$100,000-\$500,000 annually):
• Established companies seeking TransNL/Post Math integration
• 3-8 % revenue sharing on TransNL/Post Math-enabled products
• Comprehensive audit and reporting requirements
• Custom terms based on application scope
Platform License (\$500,000+ annually):
• Major technology platforms integrating TransNL/Post Math
• 5-12 % revenue sharing on TransNL/Post Math-enabled services
• Strategic partnership opportunities
• Co-development and improvement sharing
4.2 Industry-Specific Considerations
Medical/Pharmaceutical:
• Extended development timelines recognized
• Graduated payments tied to clinical trial phases
• Accelerated terms for breakthrough therapies
• Global licensing considerations
Technology/AI:
• Integration complexity assessments
• Platform vs. application differentiation
• API usage and scaling fee structures
• Open-source contribution requirements
Financial Services:
• Risk management and compliance emphasis
• Real-time monitoring and reporting
• Higher percentage rates due to direct revenue impact
• Regulatory compliance support included
SECTION 5: PROHIBITED USES AND CIRCUMVENTION
5.1 Strict Prohibitions
Licensee may NOT:
• Use TransNL/Post Math for Commercial Use without proper licensing
• Circumvent commercialization obligations through entity restructuring
• Remove attribution requirements or misrepresent Framework origins
• Reverse-engineer to avoid licensing requirements
• Use for military weapons development or harmful applications
• Transfer rights without Creator consent
• Use TransNL/Post Math for illegal purposes
• Use TransNL/Post Math for building competing services using its own Framework
• Use outputs to retrain TransNL/Post Math
5.2 Anti-Circumvention Provisions
Specifically prohibited circumvention strategies:
• Conducting research under Humanitarian Use, then commercializing through separate entities
• Licensing derived IP without acknowledging TransNL/Post Math contribution
• Using intermediary entities to obscure commercial applications
• Claiming independent development of TransNL/Post Math-enabled discoveries
Violation Consequences:
• Immediate license termination
• Treble damages for willful circumvention
• Injunctive relief and permanent licensing bans
• Public disclosure of violations
SECTION 6: MONITORING AND ENFORCEMENT
6.1 Transparency Requirements
All Licensees must:
• Register significant TransNL/Post Math applications with Creator
• Provide annual use reports for Humanitarian Use
• Notify Creator of potential commercialization within 60 days
• Maintain detailed records of TransNL/Post Math implementation and results
6.2 Creator Rights and Remedies
Creator may:
• Audit any TransNL/Post Math application with reasonable notice
• Require documentation of use categorization
• Monitor published research and patent filings
• Investigate suspected violations through legal discovery
Enforcement Mechanisms:
• Cease-and-desist notifications
• Emergency injunctive relief
• Damages calculation including lost licensing fees
• Criminal referral for willful IP theft
6.3 Community Reporting
Encouraged community oversight:
• Reward program for reporting license violations
• Whistleblower protections for internal reporters
• Public database of compliant vs. violating organizations
• Academic integrity standards enforcement
SECTION 7: INTELLECTUAL PROPERTY PROTECTION
7.1 Creator Rights Preservation
Creator retains all rights including:
• Copyrights in all TransNL/Post Math documentation and materials
• Trademark rights in “TransNL/Post Math,” “Soledad Method,” and related marks
• Patent rights in any patentable inventions and improvements
• Rights to derivative works and modifications
• Global enforcement rights across all jurisdictions
7.2 Licensee Contributions and Improvements
Improvement Sharing Framework:
• Licensees retain rights to their specific implementations
• Core Framework improvements must be shared with Creator
• Creator may incorporate improvements into future versions
• Commercial improvements subject to separate licensing terms
SECTION 8: GLOBAL COMPLIANCE AND REGULATORY
8.1 International Enforcement
Multi-jurisdictional protection:
• Registration in major IP jurisdictions (US, EU, China, etc.)
• Local legal representation in key markets
• Coordination with international IP enforcement agencies
• Compliance with varying national technology transfer laws
8.2 Export Control and Security
Compliance requirements:
• All applicable export control laws and regulations
• Technology transfer restrictions and national security requirements
• Anti-terrorism and sanctions compliance
• Data protection and privacy law adherence
8.3 Medical and Scientific Regulatory
For Medical Applications:
• FDA, EMA, and other regulatory agency compliance
• Clinical trial standards and patient safety protocols
• Medical device and pharmaceutical regulations
• Healthcare data privacy protection (HIPAA, GDPR, etc.)
SECTION 9: COMMUNITY AND COLLABORATION
9.1 Research Community Development
Creator encourages and supports:
• Collaborative research networks using TransNL/Post Math
• Open methodological sharing and improvement
• Cross-institutional research partnerships
• Publication and knowledge dissemination
9.2 Commercial Partnership Opportunities
Strategic alliances:
• Joint development agreements for major applications
• Co-investment opportunities in breakthrough companies
• Advisory positions in TransNL/Post Math-enabled ventures
• Technology transfer partnerships with universities
SECTION 10: FINANCIAL AND ECONOMIC PROVISIONS
10.1 Payment and Accounting Standards
Financial Management:
• Quarterly revenue reporting with certified accounting
• Annual third-party audits for major licensees
• Escrow accounts for disputed payments
• Multi-currency payment options and hedging
10.2 Economic Impact Sharing
Value Creation Recognition:
• Participation in economic value created through TransNL/Post Math
• Long-term royalty streams for sustainable development
• Reinvestment into Framework research and development
• Support for humanitarian applications through commercial success
SECTION 11: LIABILITY, WARRANTIES, AND DISPUTE RESOLUTION
11.1 Warranty Disclaimers
Framework provided “AS IS” with:
• No warranties of merchantability or fitness for purpose
• No guarantees of specific outcomes or results
• User assumption of implementation and application risks
• Creator liability limited to actual licensing fees paid
11.2 Dispute Resolution Framework
Structured resolution process:
1. Good-faith negotiation (30 days)
2. Mediation with IP specialist (60 days)
3. Binding arbitration with technology-expert panel in the location designated by the Creator
11.3 Indemnification
Mutual protection:
• Licensees indemnify Creator for their implementation choices
• Licensees waive their right of executing any damages against the Creator or TransNL/Post Math Network due to errors, imprecisions, mistakes made by the model, damages caused by output usage and/or data loss.
• Licensees waive the right to litigate in their jurisdiction and agree that any dispute shall be resolved through arbitration in the location designated by the Creator.
• Creator provides reasonable defense against Framework IP challenges
• Shared costs for defending against frivolous litigation
• Insurance requirements for major commercial applications
SECTION 12: FUTURE EVOLUTION AND SUSTAINABILITY
12.1 Framework Development
Continuous improvement commitment:
• Regular Framework updates and enhancements
• Community feedback integration
• Backward compatibility maintenance where possible
• Migration support for version transitions
12.2 Long-term Sustainability
Economic model designed for:
• Sustainable development through commercial revenue
• Reinvestment in humanitarian applications
• Global access expansion over time
• Research community support and growth
SECTION 13: SPECIFIC USE CASE GUIDELINES
13.1 Medical and Healthcare Applications
Free for humanity, paid for profit:
• Cancer research: FREE → Drug development: 5-10 % royalty
• Disease diagnosis tools: FREE research → Commercial devices: licensing required
• Public health analysis: FREE → Private health services: commercial license
13.2 Scientific and Environmental Applications
Research freedom with commercial accountability:
• Climate research: FREE → Carbon capture commercialization: 3-8 % royalty
• Energy research: FREE → Commercial energy products: licensing required
• Materials science: FREE → Commercial applications: percentage sharing
13.3 Educational and Academic Applications
Always free with contribution expectations:
• University research: FREE with proper attribution
• Student projects: FREE with acknowledgment
• Academic publications: FREE with citation requirements
• Commercialization of academic research: bridge provisions apply
SECTION 14: CONTACT INFORMATION AND ADMINISTRATION
14.1 Official Contacts
Contact Information:
Email: info@marte.app
Framework Creator:
Jesús Manuel Soledad Terrazas
Email: jesus@marteai.com
14.2 License Administration
Official license registry and management:
• Online license application and management portal
• Real-time compliance monitoring dashboard
• Community forum and support resources
• Regular licensing webinars and training
SECTION 15: ACCEPTANCE AND EFFECTIVENESS
15.1 Agreement Acceptance
By using, copying, distributing, or implementing the TransNL/Post Math Framework, Licensee agrees to be bound by all terms and conditions of this Agreement.
15.2 License Versions
Version Control:
• This license supersedes all previous versions
• Existing applications governed by version in effect at time of first use
• New applications subject to current license version
• Major changes announced with 90-day advance notice
SECTION 16: LEGAL EFFECTIVENESS
16.1 Governing Law and Jurisdiction
Legal Framework:
• This will be governed by Mexico City’s laws
• International IP law and treaty obligations apply
• Jurisdiction for disputes in Creator’s primary location
• Enforcement available in any jurisdiction where violations occur
16.2 Contract Integrity
Legal Validity:
• Severability of invalid provisions
• Entire agreement superseding all prior negotiations
• Amendment only through written agreement
• Survival of key provisions beyond termination
TransNL/Post Math FRAMEWORK LICENSE AGREEMENT v2.0
©️ 2025 Jesús Manuel Soledad Terrazas. All Rights Reserved
APPENDIX A: LICENSING QUICK REFERENCE
Medical/Scientific Research: FREE
Disease research
Climate science
Educational use
Non-profit humanitarian work
Commercial Applications: LICENSE REQUIRED
For-profit products
Enterprise software
Commercial services
Revenue-generating applications
Research-to-Commercial: PERCENTAGE SHARING
3-15 % of revenues from commercialized research
1-7 % of company valuations for TransNL/Post Math-core businesses
Minimum annual licensing fees for sustained commercial use
“Free tools for humanity’s challenges, fair value for commercial success.”